Pay in 4 interest-free payments of $19.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
LY-2090314
209783-80-2
InChi: InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2
CAS Number: 1619994-68-1
InChi: InChI=1S/C31H34N4O2/c1-3-34(2)31(37)24-14-17-26-27(20-24)33-30(36)28(26)29(23-10-6-4-7-11-23)32-25-15-12-22(13-16-25)21-35-18-8-5-9-19-35/h4
Afuresertib - CAS# 1047644-62-1 Catalog No.:M6803-2 LY-2090314Afuresertib, CAS No. 1047644 62 1, also known as GSK 2110183 or GSK 2110183C, is an orally bioavailable inhibitor of the serine threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Afuresertib binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K Akt signaling pathway is
US$ 104.09
US$ 1416.05
US$ 47.60
US$ 150.00
US$ 113.17